Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study

Background Patient-reported outcomes are increasingly used in the management of patients with multiple sclerosis to understand the patient's perspective of disease and treatment. These measures provide insights into important factors including treatment satisfaction, physical and psychological...

Celý popis

Podrobná bibliografia

Vydané v:	Multiple sclerosis journal - experimental, translational and clinical Ročník 8; číslo 4; s. 20552173221135888
Hlavní autori:	Wray, Sibyl, Jacques, Francois, Miller, Tamara A, Nicholas, Jacqueline A, Arroyo, Rafael, Travis, Lori, Khatri, Bhupendra, Chirieac, Magdalena, Gandhi, Roopali, Roesch, Nora, Rodrigues, Amelie, Melas-Melt, Lydie, Rawlings, Andreea M, Hunter, Samuel F
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London, England SAGE Publications 01.10.2022 Sage Publications Ltd
Predmet:	Monoclonal antibodies Multiple sclerosis Original Patients disease-modifying therapies Alemtuzumab quality of life multiple sclerosis
ISSN:	2055-2173, 2055-2173
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!